CluePoints Partners With Metrics Champion Consortium To Define Metrics And Standards For Centralized Monitoring
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) and Risk-Based Monitoring(RBM) solutions for clinical trials, announces its partnership with the Metrics Champion Consortium (MCC), an association dedicated to the development of standardized performance metrics to improve clinical trials. Drawing on the company’s vast expertise in Risk-Based Monitoring, CluePoints will work with the […]
CluePoints Introduces Data Quality Oversight Service For Site Inspection Readiness
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, today announced a new Data Quality Oversight service, RADARTM, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level. As regulators insist that sponsors adopt more comprehensive quality oversight methodologies, this new service […]
FDA Signs Agreement With CluePoints To Explore A Data-Driven Approach To Quality Oversight In Clinical Trials
Cambridge, MA –  FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research. Misconduct in clinical research, including, but not limited to the falsification or omission of data in reporting research results, places all subjects in that trial at possible safety […]
CluePoints Teams Up With Paragon Solutions To Share The Secrets Of Successful Risk-Based Monitoring Implementation
We’re delighted to announce that are our next Risk-Based Monitoring implementation webinar is open for registration! Register now – this is THE Risk-Based Monitoring webinar that you need to attend. About the Webinar With regulatory bodies such as the FDA, EMA, and the ICH all strongly influencing sponsors to adopt a risk-based and centralized approach […]
CluePoints Announces Locations For Risk-Based Monitoring Implementation Roadshows
The CluePoints and OmniComm Risk-Based Monitoring Implementation Roadshow is Coming to a City Near You! In response to the rising complexity and cost of clinical trials, the industry is shifting towards the adoption of Risk-Based Monitoring (RBM) approaches. RBM promises to improve both clinical trial efficiency and data quality. A major challenge to implementing RBM […]
CluePoints Announces Free Risk-Based Monitoring Strategy Review
We’re thrilled to announce that CluePoints is now offering a complimentary Risk-Based Monitoring strategy Check-up and Risk Management review, aimed at helping sponsors and CROs accelerate their path to successful Risk-Based Monitoring adoption. Steve Young, Senior Vice President of US Operations for CluePoints, will leverage his twenty plus years of industry experience to help companies identify how […]
CluePoints Appoints Steve Young As Senior Vice President Of US Operations
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has appointed Steve Young as Senior Vice President of its US Operations. The appointment marks a key strategic move for the company in optimizing its operational performance, customer support and service delivery across North America. Young […]
CluePoints CEO, François Torche, Honored In PharmaVOICE 100
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has today announced that its CEO, François Torche, has been selected by PharmaVOICE as one of the top 100 most influential people in the life-sciences industry. François was recognized for his pivotal role in developing and promoting Central Statistical Monitoring (CSM), a […]
CluePoints Risk-Based Monitoring Platform (Version 1.9.0) Is Live!
We’re thrilled to announce that CluePoints’ latest version (1.9.0) of the Central Monitoring platform is live! Version 1.9.0 adds an abundance of new features (as requested by customers) and extensions to existing functionality. There’s lots to cover, so let’s get started. Trends Analysis The addition of the trends analysis functionality provides the study team with a workbench […]
CluePoints Founder, Marc Buyse To Deliver Clinical Trial Data Quality Course At The ASA Biopharmaceutical Workshop
The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop is fast approaching and we’re thrilled to announce that CluePoints Founder, Marc Buyse will deliver a course with Paul Schuette, FDA; Richard C Zink, JMP Life Sciences, focused on methods to assess data integrity in clinical trials. Course: SC3 Short Course 3: An Overview of Methods to Assess Data Integrity in Clinical […]
